Related Experiment Video
Updated: Apr 23, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.6K
Health Care Provider Perceptions of Screening for Early-Stage Type 1 Diabetes-A Survey Study
Claire Cherdron1,2,3, Peter Achenbach3,4,5,6, Kathrin Ackermann3
1Institute for Medical Information Processing Biometry, and Epidemiology-IBE, LMU Munich, Munich, Germany.
Diabetes, Obesity & Metabolism
|April 22, 2026
Summary
Integrating early-stage Type 1 diabetes screening into routine care is feasible and beneficial, according to primary care providers and diabetes centers. Challenges like time constraints and reimbursement need addressing for successful implementation.
Area of Science:
- Endocrinology
- Public Health
- Primary Care Medicine
Background:
- Type 1 diabetes (T1D) screening in early stages is crucial for timely intervention.
- Integrating T1D screening into routine primary care presents opportunities and challenges.
Purpose of the Study:
- To assess the feasibility, perceived benefits, and challenges of incorporating early-stage T1D screening and monitoring into primary care settings.
- To gather insights from healthcare providers (HCPs) and specialized diabetes centers involved in the Fr1da screening program in Bavaria, Germany.
Main Methods:
- An online survey was distributed to 683 primary HCPs and 17 specialized diabetes centers participating in the Fr1da T1D screening program.
- The survey collected data on the perceived feasibility, benefits, and challenges of screening, blood sampling, and monitoring (OGTT, HbA1c).
Main Results:
- 66% of responding primary HCPs found integrating screening into routine care feasible.
- Over 70% of HCPs reported positive experiences with family communication and education.
- 80% of diabetes centers found monitoring (OGTT, HbA1c) feasible; high family acceptance was noted.
- 91% of HCPs and all centers viewed screening as beneficial, citing reduced insulin initiation and long-term care efforts.
- Key challenges included time/staffing constraints and inadequate reimbursement.
Conclusions:
- Routine implementation of early-stage T1D screening is well-supported by primary care and specialized centers.
- Refined workflows and appropriate reimbursement are essential to facilitate successful integration of T1D screening into routine care.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
5
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
5
01:22Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:29Hyperglycemia
2
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2
01:19Type I Diabetes III: Clinical Manifestations
12
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
12
01:12Type I Diabetes I: Introduction
18
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
18